Putting patients at the heart of heart failure services

Putting patients at the heart of heart failure services

MPs more interested in potholes than heart failure

MPs more interested in potholes than heart failure

UK Heart Failure Patient Charter Launch 2022

UK Heart Failure Patient Charter Launch 2022

Living well with Heart Failure report 2022

Living well with Heart Failure report 2022

DAPAGLIFLOZIN ACCEPTED FOR USE WITHIN NHS SCOTLAND

DAPAGLIFLOZIN ACCEPTED FOR USE WITHIN NHS SCOTLAND

Legal right to 2 week review of patients with suspected heart failure (HF)

Legal right to 2 week review of patients with suspected heart failure (HF)

NICE Impact Report Cardiovascular Disease Management

NICE Impact Report Cardiovascular Disease Management

NICE Recommends Dapagliflozin for Heart Failure

NICE Recommends Dapagliflozin for Heart Failure

NICE in the UK recommends Dapagliflozin (FORXIGA) to treat heart failure with reduced ejection fraction for patients with or without Diabetes.
Heart failure and Covid-19 Statement

Heart failure and Covid-19 Statement

Heart Failure Marvellous Award Winners 2021 for their outstanding contribution

Heart Failure Marvellous Award Winners 2021 for their outstanding contribution

Alice Fearn and Jai McDowall - Music Will Live in Our Hearts

Alice Fearn and Jai McDowall - Music Will Live in Our Hearts

World's First Self-Management Advent Calendar Launches

World's First Self-Management Advent Calendar Launches

European commission approves forxiga (dapagliflozin) for heart failure

European commission approves forxiga (dapagliflozin) for heart failure

Don't miss out

Sign up to our newsletter and get all the latest industry information on Events, Sales and Offers

"*" indicates required fields

This field is for validation purposes and should be left unchanged.